Search company, investor...

Predict your next investment

Venture Capital
ibhweb.com

Investments

33

Portfolio Exits

10

Funds

2

Service Providers

1

About Integra Ventures

Integra Ventures is a Seattle, Washington-based investment firm making private equity and venture capital investments across stages from seed to growth equity to recaps. Integra is primarily focused on healthcare companies based on the west coast of the United States with an emphasis on the Pacific Northwest (Oregon and Washington). Integra's investment size typically ranges from $500,000 to $2 million, and the firm generally prefers to co-invest with an investment syndicate. The firm generally aims to take a Board seat or Board observer role.

Headquarters Location

300 East Pine Street

Seattle, Washington, 98122-2029,

United States

Want to inform investors similar to Integra Ventures about your company?

Submit your Analyst Briefing to get in front of investors, customers, and partners on CB Insights’ platform.

Expert Collections containing Integra Ventures

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Find Integra Ventures in 1 Expert Collection, including Synthetic Biology.

S

Synthetic Biology

382 items

Latest Integra Ventures News

Investor Profile: Integra Ventures

Jan 14, 2013

Apple Joseph Piper from Integra Ventures is a member of FundingPost online! Venture Fund Member Profile Share This Profile: We seek investments in seed to later-stage Life Science companies. We consider business plans from experienced entrepreneurs passionately pursuing outsourcing products/services related to healthcare software applications, bio-informatics, biotechnology tools, medical devices, and the Internet. Though we seek opportunities across America, we focus on locating innovative companies in the West, and invest predominantly in companies requiring less than $5 million of initial capital. Our investments range in size from $500,000 to $3 million. We usually position our investments as a part of a syndicate, partnering with firms that also have technical or market expertise, capital depth, and/or strategic influence. We have led deals in early-stage companies as well as followed other funds in later-stage developments. Joseph Piper Managing Partner Integra Ventures Joseph Piper directs the overall investment strategy for Integra Ventures. Since 1983, he has been involved with corporate governance, formation, growth, senior management, mergers and acquisitions, and investment in the healthcare industry. He currently sits on the board of four Integra Ventures portfolio companies: National Healing, HealthHelp, Physicians Edge, and Cara Vita. Joseph also serves as an advisor to the Long Term Care Foundation, a non-profit foundation dedicated to improving the quality of life for seniors.Prior to founding Integra Ventures, Joseph co-founded and served as President of Capital Services for Diversified Health Services (DHS), the largest post-acute care outsourcing management firm in the U.S. at the time, which was later sold to ServiceMaster (NYSE: SVM).Before moving to DHS, Joseph was Chief Corporate Counsel and Chief Operating Officer for the Voluntary Hospitals of America Long Term Care Group. His duties included integrating a post-acute strategy into hospital delivery systems through acquisitions, leasing, development, financing and management of sub-acute facilities with hospitals.Early in his career, Joseph served as Corporate Counsel for The Hillhaven Corporation, the nation's second largest extended care company. As one of two staff attorneys, his responsibilities included acquiring, leasing, developing and financing 350 facilities over a 2 1/2-year period - a total capitalization of approximately $980 million.Joseph holds an M.B.A. from the University of Colorado, as well as a Juris Doctor Degree from Seattle University. He earned his B.S. in Business from Arizona State University where he also played basketball. Representative Investments Blue Heron Blue Heron is a biotechnology tools company, which has developed proprietary technology to rapidly synthesize custom-engineered genes. One of the major bottlenecks in genetic research for pharmaceutical and agricultural companies is the time and effort required to prepare genes for detailed analysis. Blue Heron's outsourced service enables researchers to go directly from planning molecules on the desktop, ordering them over the web, to testing them in the lab. Blue Heron targets difficult to clone genes and variants that biotech companies are unable to produce themselves. Calypso Medical Technologies, Inc. Calypso Medical Technologies, Inc., is an early-stage medical device company founded in 1999. In the next few years, cancer will exceed heart disease as the leading cause of death in the US. We believe there are significant unmet needs in the treatment of cancer. The company is developing innovative tools and therapies for the oncology market that address these unmet needs. Calypso has assembled an experienced management team, world-class biomedical engineers and scientists, and an extensive scientific advisory board that rivals established medical technology organizations. Cara Vita Cara Vita has developed a cost-effective health maintenance approach to caring for the chronically frail elderly in non-skilled settings. While principally a residential care provider, Cara Vita has integrated private home health and day care programs into its facilities to provide an alternative for those seniors and their families who are not yet prepared for a residential program. Cara Vita is built on a care model designed to enhance resident health and allow high acuity residents to remain in Cara Vita's facilities longer, and age in place gracefully. National Healing National Healing is a disease management company with a focused expertise in managing wound treatment centers inside client hospitals. The Company has established 40 clinics with hospital clients including: Columbia, Quorum, MedCath, and several independent hospitals. In their centers, National Healing provides high-quality, cost-effective methodologies to expedite the healing of wounds and reduce inpatient stays. About FundingPost For over Fourteen Years FundingPost has worked with thousandsof Angel and Venture Capital Investors. We believe that it isimportant to reach investors in every medium possible -both online and offline. We have been directly responsible fortons of success stories and Millions and Millions of dollars raised.We look forward to introducing your company to the leading Venture and Angel Investors nationwide. Sign up now: Entrepreneurs / Investors Join the FundingPost email list and learn how, when and where you can meet these Investors: Other Venture Profiles:

Integra Ventures Investments

33 Investments

Integra Ventures has made 33 investments. Their latest investment was in Kerdea Technologies as part of their Unattributed VC on May 5, 2020.

CBI Logo

Integra Ventures Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

5/5/2020

Unattributed VC

Kerdea Technologies

$0.15M

Yes

1

8/2/2013

Unattributed VC

MediQuest Therapeutics

$0.25M

No

1

2/28/2013

Series B

Ampla Pharmaceuticals

$3.65M

No

1

10/5/2011

Series D - II

Subscribe to see more

$99M

Subscribe to see more

0

5/18/2011

Series B - III

Subscribe to see more

$99M

Subscribe to see more

0

Date

5/5/2020

8/2/2013

2/28/2013

10/5/2011

5/18/2011

Round

Unattributed VC

Unattributed VC

Series B

Series D - II

Series B - III

Company

Kerdea Technologies

MediQuest Therapeutics

Ampla Pharmaceuticals

Subscribe to see more

Subscribe to see more

Amount

$0.15M

$0.25M

$3.65M

$99M

$99M

New?

Yes

No

No

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

1

1

1

0

0

Integra Ventures Portfolio Exits

10 Portfolio Exits

Integra Ventures has 10 portfolio exits. Their latest portfolio exit was Tepha on July 27, 2021.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

7/27/2021

Acquired

$99M

3

3/15/2017

Acquired

$99M

3

12/22/2016

Reverse Merger

$99M

3

9/22/2011

Acquired

Subscribe to see more

$99M

Subscribe to see more

10

9/1/2011

Acquired

Subscribe to see more

$99M

Subscribe to see more

10

Date

7/27/2021

3/15/2017

12/22/2016

9/22/2011

9/1/2011

Exit

Acquired

Acquired

Reverse Merger

Acquired

Acquired

Companies

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

$99M

$99M

Acquirer

Subscribe to see more

Subscribe to see more

Sources

3

3

3

10

10

Integra Ventures Fund History

2 Fund Histories

Integra Ventures has 2 funds, including IV-III LP.

Closing Date

Fund

Fund Type

Status

Amount

Sources

10/1/2002

IV-III LP

Early-Stage Venture Capital

Closed

$33M

1

12/31/1998

IBH II LP

Subscribe to see more

Subscribe to see more

$99M

10

Closing Date

10/1/2002

12/31/1998

Fund

IV-III LP

IBH II LP

Fund Type

Early-Stage Venture Capital

Subscribe to see more

Status

Closed

Subscribe to see more

Amount

$33M

$99M

Sources

1

10

Integra Ventures Service Providers

1 Service Provider

Integra Ventures has 1 service provider relationship

Service Provider

Associated Rounds

Provider Type

Service Type

Counsel

General Counsel

Service Provider

Associated Rounds

Provider Type

Counsel

Service Type

General Counsel

Partnership data by VentureSource

Integra Ventures Team

1 Team Member

Integra Ventures has 1 team member, including current Founder, Managing Director, Joseph Piper.

Name

Work History

Title

Status

Joseph Piper

Founder, Managing Director

Current

Name

Joseph Piper

Work History

Title

Founder, Managing Director

Status

Current

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Join a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.